Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
about
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureusTreatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combinationEvaluation of quinolones in experimental animal models of infections.Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditisComparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.Methicillin-resistant staphylococci: detection methods and treatment of infections.Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.Methicillin-resistant staphylococci.Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditisMode of action, and in vitro and in vivo activities of the fluoroquinolones.Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureusEvaluation of pefloxacin in experimental Escherichia coli meningitis.Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.Alterations of coagulase-negative staphylococcal flora in cardiac surgery patients: comparative study between cefamandole and pefloxacin perioperative prophylaxis.Macrolides: problems and promises.The place of quinolones in antibacterial therapy in hospitals.
P2860
Q28361126-3611A4CF-5503-461B-943D-A90A2852001DQ28361860-CFDC1736-FDAF-4117-ABBA-FA7ABB1C1491Q30446615-BBC7A733-DA98-471E-A582-0029716E9B97Q35248574-6DA6B664-9048-4166-94AF-E5E0784647EFQ35292551-961E1C12-BC63-421E-943C-07CC2465B0D6Q35566190-F9712B79-FCF2-48A5-A9AC-D7D883DB2F4CQ35648839-2C2AD2A5-03EA-4A78-A6A4-060CA0051C07Q36632851-127D9193-9841-45CF-AFEB-822A30904CA8Q36754440-70E0AEF9-03C9-4722-B2EF-094DD43BAE4FQ39637667-F6DB1BA8-3836-45EF-A7F7-938760DD7CA4Q39819019-22034AA5-6AA7-4CA3-BBE3-969CC6B5770BQ39834459-26A5B77C-35F7-4F8E-9DDF-BC88B4748AB0Q39850884-D9780DB9-3D52-4904-A84E-8526DBE2F78AQ39851504-A8547DDE-8BF9-4FDF-BD2E-F18D2B11EE3EQ46926939-3D232F72-D15F-404B-B24A-70935FFFA61CQ54388935-95387649-1ADE-4952-AE8E-80B0B77EC086Q54432495-A8C3D0BD-2FCE-424C-A6A4-DA6A396246BC
P2860
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@en
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@nl
type
label
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@en
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@nl
prefLabel
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@en
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Pefloxacin therapy for experim ...... ains of Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.27.5.685
P407
P577
1985-05-01T00:00:00Z